Stimulants create more than one treatment need
Stimulant use disorder can involve cocaine, methamphetamine, prescription stimulants, or other stimulant products and may affect sleep, mood, cognition, the heart, and daily functioning. A useful assessment distinguishes the substance and route, prescribed use from misuse, other drugs, psychiatric symptoms, and urgent medical risks. Cocaine, methamphetamine, and prescription stimulant misuse may differ in duration, route, and associated risks. The assessment should also look for opioid exposure, since an unexpected contaminant can change overdose planning.
Contingency management should be specific
There is no FDA-approved medication specifically for stimulant use disorder. NIDA identifies contingency management as the most effective established behavioral treatment for methamphetamine use disorder, while cognitive behavioral and motivational approaches may also be included in a broader plan. Ask what behavior earns an incentive, how often it is measured, and how rewards are delivered over time. A vague promise of prizes is not the same as a structured protocol with consistent rules and clinical oversight.
Recovery routines repair neglected basics
Treatment may use structured incentives for attendance or drug-negative tests, coping skills, motivational work, individual and group therapy, drug testing with consent, and recovery support. Clinicians should also address depression, psychosis, sleep, nutrition, trauma, tobacco, alcohol, opioids, and practical barriers to attendance. Early care often needs deliberate attention to sleep, meals, dental health, hydration, appointments, and a safe place to rest. These practical needs support participation in therapy but do not replace medical evaluation after severe symptoms.
Psychosis and heart symptoms require rapid action
Stimulants can contribute to chest pain, abnormal heart rhythms, stroke, seizures, overheating, severe agitation, paranoia, hallucinations, and suicidal behavior. Call 911 for any serious or rapidly worsening sign, and carry naloxone because stimulants from the unregulated supply may contain an opioid. Paranoia or hallucinations may continue after intoxication and should be assessed instead of dismissed as bad behavior. Chest pain, neurologic changes, overheating, or a seizure can signal an emergency that a counseling visit cannot manage.
Look beyond a generic group schedule
Ask whether the program offers a tested contingency management protocol with clear targets and meaningful incentives, not only general rewards. Confirm access to medical and psychiatric clinicians, how stimulant-induced psychosis is evaluated, and how the program treats simultaneous opioid or alcohol use. Confirm that the program can deliver stimulant-focused care and does not reserve its effective services only for opioid or alcohol diagnoses. Ask how psychiatric symptoms are monitored and whether prescribers and medical clinicians are accessible.
Make return to care easy after renewed use
Arrange a full assessment after any medical or psychiatric emergency and bring information about prescribed stimulants and other substances. Build an immediate plan for sleep, food, hydration, safe contacts, high-risk settings, naloxone, and rapid re-entry to care after renewed use. Save the program number, transportation option, and a supportive contact before a high-risk period occurs. A rapid, nonpunitive appointment can prevent one episode from turning into a prolonged break from treatment.
What to verify about a stimulant treatment program
Request a clear description of contingency management, including frequency, targets, and who administers it. Ask how the program responds to psychosis, depression, suicidal thinking, and possible opioid exposure. Confirm that prescribed stimulants are reviewed individually rather than stopped automatically. The discharge plan should include ongoing behavioral care, named follow-up clinicians, transportation details, and a prompt route back after renewed use or missed appointments.